icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
no clinical added value
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients.
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
bZDfJ2Zy1VfHzjHS
Listen
